Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Prelude Therapeutics Incorporated (PRLD)

Compare
0.7703
+0.0023
+(0.30%)
At close: April 1 at 4:00:00 PM EDT
0.8200
+0.05
+(6.45%)
After hours: April 1 at 7:54:26 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,000
7,000
--
--
--
Operating Expense
146,714
146,714
132,277
123,540
113,735
Operating Income
-139,714
-139,714
-132,277
-123,540
-113,735
Other Income Expense
12,541
12,541
10,445
8,102
2,041
Pretax Income
-127,173
-127,173
-121,832
-115,438
-111,694
Net Income Common Stockholders
-127,173
-127,173
-121,832
-115,438
-111,694
Diluted NI Available to Com Stockholders
-127,173
-127,173
-121,832
-115,438
-111,694
Basic EPS
-1.68
--
-2.02
-2.44
-2.43
Diluted EPS
-1.68
--
-2.02
-2.44
-2.43
Basic Average Shares
75,805.8400
--
60,357.0520
47,371.5890
46,049.7630
Diluted Average Shares
75,805.8400
--
60,357.0520
47,371.5890
46,049.7630
Total Operating Income as Reported
-139,714
-139,714
-132,277
-123,540
-113,735
Total Expenses
146,714
146,714
132,277
123,540
113,735
Net Income from Continuing & Discontinued Operation
-127,173
-127,173
-121,832
-115,438
-111,694
Normalized Income
-127,173
-127,173
-121,832
-115,438
-111,694
EBIT
-139,714
-139,714
-132,277
-123,540
-113,735
EBITDA
-137,942
-137,942
-131,108
-122,216
-112,820
Reconciled Depreciation
1,772
1,772
1,169
1,324
915
Net Income from Continuing Operation Net Minority Interest
-127,173
-127,173
-121,832
-115,438
-111,694
Normalized EBITDA
-137,942
-137,942
-131,108
-122,216
-112,820
12/31/2021 - 9/25/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SNSE Sensei Biotherapeutics, Inc.
0.3450
-12.44%
 
PLRZ Polyrizon Ltd.
0.3646
-1.19%
 
CDT Conduit Pharmaceuticals Inc.
0.7221
-7.54%
 
FHTX Foghorn Therapeutics Inc.
3.3750
-7.53%
 
LYEL Lyell Immunopharma, Inc.
0.4843
-9.98%
 
ONCO Onconetix, Inc.
0.0757
-2.95%
 
ALMS Alumis Inc.
7.24
+17.92%
 
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
 
RGLS Regulus Therapeutics Inc.
1.7500
0.00%
 
NKTX Nkarta, Inc.
1.8450
+0.27%